TELA Bio, Inc.
TELA
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix prā¦ read more
Healthcare
Medical Devices
6 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.73
Price+2.83%
$0.02
1Y
Price
Market Cap
$32.675m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-34.6%
EBITDA Margin-41.6%
Net Profit Margin-28.7%
Free Cash Flow Margin-34.6%
EBITDA Margin-41.6%
Net Profit Margin-28.7%
Free Cash Flow MarginRevenue
$80.814m
+11.2%
1y CAGR+23.6%
3y CAGR+27.9%
5y CAGREarnings
-$39.840m
-3.1%
1y CAGR+3.5%
3y CAGR-5.6%
5y CAGREPS
-$0.79
+33.1%
1y CAGR+31.1%
3y CAGR+18.6%
5y CAGRBook Value
-$5.201m
$69.891m
Assets$75.092m
Liabilities$56.393m
DebtDebt to Assets
80.7%
-1.3x
Debt to EBITDAFree Cash Flow
-$30.199m
+26.0%
1y CAGR+8.7%
3y CAGR-2.8%
5y CAGRNo items found.
Press Releases
Statements and updates from the company